| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |